A new wave of Covid-19 is spreading across Asia, driven by the Covid JN.1 variant and its descendants, and India has recorded 257 active cases, with Kerala, Maharashtra and Tamil Nadu reporting the maximum numbers. Health experts, however, say there is no need to panic: the infections are mostly mild and not associated with unusual severity or mortality.
Maharashtra has recorded a notable uptick, with active cases spiking from 12 to 56 in a single week. “India stands at 257 cases and is monitoring the situation with increased vigilance. As per the preliminary information available, the cases are mostly mild, not associated with unusual severity or mortality,” health officials told PTI.
Covid JN.1: what we know about the variant
Covid JN.1 is a descendant of the BA.2.86 variant, itself an Omicron subvariant. The World Health Organization has classified JN.1 as a “variant of interest” but not yet a “variant of concern,” and WHO has assessed the global public-health risk posed by the strain as low.
The current Asia surge is attributed primarily to Covid JN.1 and its descendants, particularly LF.7 and NB.1.8, which are subvariants of the Omicron lineage circulating rapidly. Health authorities in Hong Kong, Singapore, China and Thailand have urged people to take new booster vaccinations as cases climb across the region.
Covid JN.1 symptoms to watch out for
Common Covid JN.1 symptoms mirror earlier Omicron infections: fever, sore throat, runny nose, headaches and muscle weakness. However, JN.1 can also cause gastrointestinal problems that set it apart from some earlier strains. Diarrhoea, loss of appetite, persistent nausea and extreme fatigue are among the less typical symptoms reported.
“Currently, we are seeing an increase in cases attributed to Covid JN.1, which is a subvariant of Omicron. While the symptoms tend to be mild, including fever, cold, cough, and loss of smell or taste, it remains highly contagious,” said Dr Sharad Joshi, Director and HOD of Pulmonology and Paediatric Pulmonology at Max Healthcare.
What officials in India advise
Officials say the central government has directed states and Union territories to remain vigilant, ensure compliance with the revised Covid surveillance strategy, and monitor influenza-like illness and severe acute respiratory illness cases at the district level for early trend detection. Current vaccines and treatments remain effective against the new subvariants, health authorities emphasise, and there is no indication that Covid JN.1 significantly evades immunity from vaccines or past infections.
Doctors advise anyone developing fever, respiratory symptoms or the characteristic gastrointestinal signs to get tested, self-isolate and stay hydrated, seeking medical help if breathing difficulties develop. Keeping vaccinations up to date, including boosters, remains the best defence against severe illness as the Covid JN.1 wave moves through the region.
Putting the numbers in context
The current numbers remain tiny compared with pandemic peaks, when India reported hundreds of thousands of cases a day. While the Singapore health ministry has noted that waning population immunity may be contributing to the rise, it has also said there is no indication that circulating variants are more transmissible or cause more severe cases than during the pandemic. Vigilance, not alarm, is the official posture.
Surveillance and boosters are the official playbook
The central government’s response follows the revised Covid surveillance strategy issued by the Union Ministry of Health and Family Welfare. States have been told to monitor influenza-like illness and severe acute respiratory illness cases at the district level so that early trends are detected before they become waves, and to ensure strict compliance with reporting guidelines.
Health authorities across Asia are pushing boosters as the immediate line of defence. In Hong Kong and Singapore, officials have urged residents to take new booster vaccinations, and Singapore’s health ministry has said that while waning population immunity may be contributing to the rise, there is no indication that circulating variants are more transmissible or cause more severe disease than during the pandemic. For individuals, the advice remains familiar: get tested if symptoms appear, self-isolate, stay hydrated and rest, and seek medical help if breathing becomes difficult. Keeping vaccinations up to date, including boosters, remains the best protection against severe illness.